Tackling the clinical complexity of breast cancer
- PMID: 35855461
- PMCID: PMC9255264
- DOI: 10.7573/dic.2022-2-3
Tackling the clinical complexity of breast cancer
Abstract
Clinical complexity (CC) is an increasingly recognized feature of internal medicine patients who are often characterized by complex needs determined by both biological (i.e. intrinsic to the patient or disease biology) and non-biological (i.e. socioeconomic, cultural, environmental, behavioural) factors. Breast cancer, one of the most common malignancies worldwide, certainly represents an example of a complex disease. Nonetheless, the concept itself of CC and its possible determinants in breast cancer have been poorly addressed. We herein provide our view about the possible factors triggering CC, the key issues of CC and the related unmet needs in breast cancer.
Keywords: cancer; internal medicine; multimorbidity; oncology.
Copyright © 2022 Lenti MV, Sottotetti F, Corazza GR.
Conflict of interest statement
Disclosure and potential conflicts of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of this article. The International Committee of Medical Journal Editors (ICMJE) Potential Conflicts of Interests form for the authors is available for download at: https://www.drugsincontext.com/wp-content/uploads/2022/05/dic.2022-2-3-COI.pdf
Similar articles
-
Bringing complexity into clinical practice: An internistic approach.Eur J Intern Med. 2019 Mar;61:9-14. doi: 10.1016/j.ejim.2018.11.009. Epub 2018 Dec 6. Eur J Intern Med. 2019. PMID: 30528261 Review.
-
A consensus for the development of a vector model to assess clinical complexity.Intern Emerg Med. 2017 Dec;12(8):1313-1318. doi: 10.1007/s11739-017-1709-6. Epub 2017 Jul 14. Intern Emerg Med. 2017. PMID: 28710713
-
The association of health-related quality of life with unmet supportive care needs and sociodemographic factors in low-income Latina breast cancer survivors: a single-centre pilot study.Disabil Rehabil. 2019 Dec;41(26):3151-3156. doi: 10.1080/09638288.2018.1485179. Epub 2018 Jul 27. Disabil Rehabil. 2019. PMID: 30052478
-
Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project.Breast Cancer. 2021 Mar;28(2):289-297. doi: 10.1007/s12282-020-01156-2. Epub 2020 Sep 14. Breast Cancer. 2021. PMID: 32929637
-
The Role of Artificial Intelligence in Managing Multimorbidity and Cancer.J Pers Med. 2021 Apr 19;11(4):314. doi: 10.3390/jpm11040314. J Pers Med. 2021. PMID: 33921621 Free PMC article. Review.
Cited by
-
Prognostic Potential of Immune Inflammatory Biomarkers in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.Cancers (Basel). 2022 Oct 27;14(21):5287. doi: 10.3390/cancers14215287. Cancers (Basel). 2022. PMID: 36358706 Free PMC article.
-
Towards Agility in Breast Cancer Treatment Principles as Adopted from Agile Software Engineering.J Multidiscip Healthc. 2024 Mar 23;17:1315-1341. doi: 10.2147/JMDH.S449465. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38545433 Free PMC article.
-
Hypermethylation of the Gene Body in SRCIN1 Is Involved in Breast Cancer Cell Proliferation and Is a Potential Blood-Based Biomarker for Early Detection and a Poor Prognosis.Biomolecules. 2024 May 12;14(5):571. doi: 10.3390/biom14050571. Biomolecules. 2024. PMID: 38785978 Free PMC article.
-
The meaning of trust along the treatment pathway of women with breast cancer: a mixed-methods study among cancer survivors.BMC Womens Health. 2025 Jan 15;25(1):25. doi: 10.1186/s12905-024-03540-y. BMC Womens Health. 2025. PMID: 39815217 Free PMC article.
-
Health-related quality of life and clinical complexity of a real-life cohort of patients with advanced HR+/HER2- breast cancer treated with CDK4/6 inhibitors and endocrine therapy.Drugs Context. 2023 Jun 20;12:2023-1-7. doi: 10.7573/dic.2023-1-7. eCollection 2023. Drugs Context. 2023. PMID: 37378079 Free PMC article.
References
LinkOut - more resources
Full Text Sources